Table 1

Daily relationships (r values) between cocaine intake (mg/kg over the entire 10-h session) and postsession plasma PRL and CORT determined on each of the 5 consecutive days of testing for groups of rats provided access to one of the four doses of cocaine for SA

BaselineSA Test Day
Day 1Day 2Day 3Day 4Day 5
PRL CORTCocaine IntakePRL CORTrValueCocaine IntakePRL CORTrValueCocaine IntakePRL CORTrValueCocaine IntakePRL CORTrValueCocaine IntakePRL CORTr Value
Cocaine (mg/kg/infusion) ng/ml mg/kg ng/ml mg/kg ng/ml mg/kg ng/ml mg/kg ng/ml mg/kg ng/ml
 0.256.06  ± 1.8415.96  ± 3.653.05  ± 0.66−0.31518.09  ± 4.331.86  ± 0.56−0.01916.96  ± 3.793.35  ± 1.10 0.06325.07  ± 4.751.64  ± 0.84−0.12726.75  ± 5.782.38  ± 0.78−0.175
73.35  ± 14.60141.35  ± 46.83 0.7861-a 97.88  ± 26.15 0.6931-a 114.29  ± 22.61 0.401155.86  ± 36.62 0.562232.28  ± 48.18 0.6241-a
 0.56.48  ± 1.6026.32  ± 5.682.17  ± 0.75−0.03125.07  ± 4.752.50  ± 0.74−0.25426.96  ± 5.721.46  ± 0.92−0.60034.18  ± 5.260.90  ± 0.33−0.21848.50  ± 6.021.28  ± 0.54−0.516
64.26  ± 19.55113.25  ± 34.52 0.435165.18  ± 36.78 0.7621-a 160.72  ± 38.14 0.7401-a 172.48  ± 42.86 0.366212.37  ± 40.24 0.7871-a
 1.06.20  ± 1.4241.83  ± 7.652.05  ± 1.15−0.7131-b 47.33  ± 7.671.43  ± 0.46−0.6501-b 61.58  ± 9.631.85  ± 0.43−0.63268.58  ± 10.911.04  ± 0.52−0.31474.92  ± 9.242.89  ± 0.99−0.033
39.96  ± 17.46191.57  ± 43.72 0.8091-a 126.45  ± 20.50 0.8271-a 212.30  ± 25.810.424228.09  ± 36.74 0.455210.95  ± 43.92 0.613
 2.07.49  ± 2.462.55  ± 10.760.88  ± 0.42−0.53270.36  ± 7.722.17  ± 0.77 0.08785.82  ± 7.653.77  ± 0.79 0.20695.46  ± 8.532.76  ± 1.42 0.507102.18  ± 9.283.25  ± 0.98 0.348
34.51  ± 10.32157.99  ± 37.68 0.8451-a 184.16  ± 24.30 0.339238.47  ± 31.38 0.453204.20  ± 30.82 0.586209.81  ± 35.96 0.8061-a

The r values were determined using linear regression analysis. Intakes represent the total cocaine intake during the 10-h SA session, immediately after which blood samples were obtained for hormonal determinations. Values are mean ± S.E.

  • 1-a Significant positive correlation (P < .05).

  • 1-b Significant negative correlation (P < .05).